A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation

Head Lice Infestation Clinical Trial

Official title:
A Pediatric Safety and Pharmacokinetic Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation

Status Completed

Clinical Trial Summary

The primary purpose of the study is to evaluate safety and tolerability of a single application of Ha44 Gel 0.74% w/w for the treatment of head lice. Secondary purpose is to evaluate PK of Ha44 and benzyl alcohol under conditions of maximal exposure in pediatric population.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02010333
Study type	Interventional
Source	Dr. Reddy's Laboratories Limited
Contact
Status	Completed
Phase	Phase 2
Start date	April 2013
Completion date	August 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02097485` - Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation	Phase 2
Recruiting	`NCT04878276` - Comparative Head Lice Therapy With Dimet 5® vs. Hedrin® Once
Completed	`NCT01907490` - Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice Infestation	Phase 2
Completed	`NCT02062060` - Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation	Phase 3
Completed	`NCT02060903` - A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation	Phase 3
Recruiting	`NCT06057506` - Comparative Study for the Evaluation of Two Medical Devices on the Treatment of Head Lice Infestation	N/A